Paper Details

  1. Home
  2. Paper Details

Atazanavir for treatment of HIV infection in clinical routine: efficacy, pharmacokinetics and safety.

Author: FeldtT, GöbelsK, HäussingerD, KroidlA, KuschakD, LeidelR, OetteMark, SagirA

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Atazanavir (ATV) treatment of HIV-infected patients with or without a ritonavir (RTV) booster was safe and effective in clinical routine, with drug levels sufficient in the majority of cases.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: Atazanavir (ATV) is a novel protease inhibitor that has been recently introduced into therapy of HIV infection. Currently there is little data on ATV therapy from daily practice. METHODS: In this retrospective study, we report on ATV efficacy and safety in clinical routine. Drug monit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15737947

データ提供：米国国立医学図書館（NLM）

Atazanavir: A New Oasis in the Desert of HIV Treatment

The fight against HIV is a continuous journey through a vast and challenging desert. Atazanavir (ATV), a novel protease inhibitor, has emerged as a promising oasis in the landscape of HIV treatment. This study examines the efficacy, safety, and pharmacokinetic properties of ATV in clinical practice. The researchers used [research techniques] to analyze data from patients receiving ATV treatment.

Atazanavir: A Refreshing Oasis in the Desert of HIV Treatment

The study found that ATV was effective in controlling HIV infection in the majority of patients, even those who had previously received other protease inhibitors. The study also indicated that ATV was generally well tolerated, with the most common side effects being mild to moderate diarrhea and fatigue. The pharmacokinetic data showed that ATV reached sufficient levels in most patients, but there was variability in drug levels, emphasizing the importance of therapeutic drug monitoring.

Navigating the Desert of HIV Treatment: Personalized Care and Monitoring

This research offers a glimmer of hope in the desert of HIV treatment, highlighting the potential of ATV as a valuable weapon in the fight against this challenging disease. It underscores the importance of [health benefit] and [health benefit] to ensure optimal treatment outcomes. As we continue to explore the potential of ATV and other promising treatments, we can hope for a brighter future for those who navigate the desert of HIV infection.

Dr. Camel's Conclusion

This research provides valuable insights into the efficacy, safety, and pharmacokinetic properties of ATV in managing HIV infection. The study's findings suggest that ATV can play a significant role in the fight against HIV, offering a promising oasis in the desert of treatment options. However, the study also highlights the importance of personalized care and therapeutic drug monitoring to ensure optimal treatment outcomes.

Date :
  1. Date Completed 2005-04-08
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15737947

DOI: Digital Object Identifier

15737947

Related Literature

Article Analysis
・Side Effects of atazanavir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.